20,623 Shares in Agilent Technologies, Inc. $A Acquired by Journey Advisory Group LLC

Key Points

• Journey Advisory Group LLC acquired 20,623 shares of Agilent Technologies, valued at approximately $2.43 million, indicating growing institutional interest in the company.
• Agilent Technologies received a range of analyst upgrades, with TD Cowen raising their price target from $150 to $162 and maintaining a "buy" rating.
• The company recently declared a quarterly dividend of $0.248, reflecting a 0.7% yield and a payout ratio of 23.24%.

Journey Advisory Group LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 20,623 shares of the medical research company's stock, valued at approximately $2,434,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Chicago Partners Investment Group LLC lifted its holdings in Agilent Technologies by 85.9% during the second quarter. Chicago Partners Investment Group LLC now owns 3,632 shares of the medical research company's stock worth $434,000 after acquiring an additional 1,678 shares in the last quarter. TrueMark Investments LLC acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $1,999,000. William Blair Investment Management LLC lifted its stake in Agilent Technologies by 19.7% in the second quarter. William Blair Investment Management LLC now owns 2,214,487 shares of the medical research company's stock valued at $261,332,000 after buying an additional 364,099 shares in the last quarter. Carmel Capital Partners LLC lifted its stake in Agilent Technologies by 32.3% in the second quarter. Carmel Capital Partners LLC now owns 10,928 shares of the medical research company's stock valued at $1,290,000 after buying an additional 2,667 shares in the last quarter. Finally, Chevy Chase Trust Holdings LLC increased its position in shares of Agilent Technologies by 0.6% during the second quarter. Chevy Chase Trust Holdings LLC now owns 152,236 shares of the medical research company's stock worth $17,965,000 after acquiring an additional 868 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on A shares. TD Cowen boosted their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a "buy" rating in a research report on Tuesday, October 14th. Barclays lifted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a report on Thursday, October 2nd. Robert W. Baird increased their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a report on Thursday, August 28th. Weiss Ratings reiterated a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Finally, Rothschild & Co Redburn began coverage on Agilent Technologies in a report on Wednesday, October 8th. They set a "buy" rating and a $165.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $149.62.

Agilent Technologies Stock Up 0.6%

A stock opened at $142.01 on Monday. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The business's 50 day simple moving average is $127.58 and its 200 day simple moving average is $117.90. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $40.26 billion, a PE ratio of 33.34, a PEG ratio of 4.63 and a beta of 1.26.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies's payout ratio is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.